Novel enantiomerically pure betaagonists, method for the production and the use thereof in the form of a drug

Details for Australian Patent Application No. 2005243469 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sieger, Peter; Lustenberger, Philipp; Konetzki, Ingo

Agent Davies Collison Cave

Pub. Number AU-B-2005243469

PCT Pub. Number WO2005/111005

Priority 10 2004 024 454.5 14.05.04 DE

Filing date 11 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 29 September 2011

International Classifications

C07D 265/36 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/111005 Priority application(s): WO2005/111005

29 September 2011 Application Accepted

  Published as AU-B-2005243469

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243474-Method for producing shaped bodies made from crosslinked gelatine

2005243465-Novel CIS-imidazolines